Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Foster

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
BMJ Quality & Safety|April 11, 2025
Support for hospital doctors' workplace well-being in England: the Care Under Pressure 3 realist evaluationAnna Melvin, Alison Pearson, Daniele Carrieri, et al.
Arthritis Research & Therapy|February 27, 2026
The challenges and opportunities for equitable global access to medications for paediatric rheumatology in low-to middle-income countries: a review on behalf of the Paediatric Global Task Force for Musculoskeletal HealthChristiaan Scott, Waheba Slamang, Molly Dushnicky, et al.
Neuromuscular Disorders : NMD|June 23, 2009
Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult miceAntonios Matsakas, Keith Foster, Anthony Otto, et al.
Pediatric Rheumatology Online Journal|December 6, 2018
Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trialsFrances C Sherratt, Louise Roper, Simon R Stones, et al.
Rheumatology (Oxford, England)|June 28, 2019
CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritisFlora McErlane, Gillian Armitt, Joanna Cobb, et al.
Annals of the Rheumatic Diseases|April 9, 2017
How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Eileen Baildam, et al.
Eclinicalmedicine|August 8, 2019
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trialMadeleine Rooney, Nick Bishop, Joyce Davidson, et al.
Rejuvenation Research|May 2, 2009
Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscleKeith Foster, Ian R Graham, Anthony Otto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of DefinitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Janet E McDonagh, et al.
Journal of Orthodontics|May 5, 2010
Juvenile idiopathic arthritis (JIA): a screening study to measure class II skeletal pattern, TMJ PDS and use of systemic corticosteroidsNicky A Mandall, Robin Gray, Kevin D O'Brien, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
BMJ Quality & Safety|April 11, 2025
Support for hospital doctors' workplace well-being in England: the Care Under Pressure 3 realist evaluationAnna Melvin, Alison Pearson, Daniele Carrieri, et al.
Arthritis Research & Therapy|February 27, 2026
The challenges and opportunities for equitable global access to medications for paediatric rheumatology in low-to middle-income countries: a review on behalf of the Paediatric Global Task Force for Musculoskeletal HealthChristiaan Scott, Waheba Slamang, Molly Dushnicky, et al.
Neuromuscular Disorders : NMD|June 23, 2009
Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult miceAntonios Matsakas, Keith Foster, Anthony Otto, et al.
Pediatric Rheumatology Online Journal|December 6, 2018
Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trialsFrances C Sherratt, Louise Roper, Simon R Stones, et al.
Rheumatology (Oxford, England)|June 28, 2019
CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritisFlora McErlane, Gillian Armitt, Joanna Cobb, et al.
Annals of the Rheumatic Diseases|April 9, 2017
How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Eileen Baildam, et al.
Eclinicalmedicine|August 8, 2019
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trialMadeleine Rooney, Nick Bishop, Joyce Davidson, et al.
Rejuvenation Research|May 2, 2009
Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscleKeith Foster, Ian R Graham, Anthony Otto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of DefinitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Janet E McDonagh, et al.
Journal of Orthodontics|May 5, 2010
Juvenile idiopathic arthritis (JIA): a screening study to measure class II skeletal pattern, TMJ PDS and use of systemic corticosteroidsNicky A Mandall, Robin Gray, Kevin D O'Brien, et al.
Pageof 6